| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.9M | +20.4% |
| Cost of Revenue | $1.6M | +1.3% |
| Gross Profit | $2.4M | +37.8% |
| R&D Expense | $2.1M | -17.4% |
| SG&A Expense | $7.0M | -10.2% |
| Operating Income | -$12.8M | +7.1% |
| Net Income | -$12.6M | +8.2% |
| EPS (Basic) | -$1.70 | +84.9% |
| EPS (Diluted) | -$1.70 | +84.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | -42.5% |
| Accounts Receivable | $1.7M | +96.8% |
| Inventory | $1.1M | +73.9% |
| Current Assets | $6.8M | -17.6% |
| Total Assets | $10.8M | +9.3% |
| Current Liabilities | $3.2M | +71.9% |
| Total Liabilities | $5.7M | +47.7% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.7M | -8.8% |
| Capital Expenditures | $273K | +46.8% |
| Investing Cash Flow | -$1.0M | -450.0% |
| Financing Cash Flow | $9.0M | -36.4% |
| Free Cash Flow | -$11.0M | -9.5% |
| $5.0M |
| -15.6% |